2025 annual financial data
Intellia Therapeutics 2025 Operating margin
Intellia Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -651.67%.
Operating income was -440,990,000 USD and net income was -412,694,000 USD.
Operating cash flow was -348,880,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,671,000 USD
- Operating income
- -440,990,000 USD
- Net income
- -412,694,000 USD
- Operating cash flow
- -348,880,000 USD